Literature DB >> 11753992

Small cell undifferentiated histology in hepatoblastoma may be unfavorable.

J E Haas1, J H Feusner, M J Finegold.   

Abstract

BACKGROUND: Chemotherapy has improved the prognosis of hepatoblastoma demonstrably. It renders seemingly unresectable primary tumors amenable to surgery and can cure metastases. Some authors advocate preoperative chemotherapy for patients with tumors that are deemed resectable, relying solely on percutaneous biopsy or even on diagnostic imaging and elevated serum alpha-fetoprotein levels for diagnosis. However, certain cytologic features of hepatoblastoma appear to have important prognostic consequences. Well differentiated fetal hepatoblastomas that are confined to the liver and that have minimal mitotic activity may not require additional therapy if they are resected totally.
METHODS: In the current study 16 completely resected hepatoblastomas that exhibited partial or predominant small cell undifferentiated histology were identified retrospectively and correlated with patient outcome.
RESULTS: Ten of 16 patients with completely resected tumors exhibiting small cell undifferentiated histology developed a disease recurrence. Five of these recurrences were fatal.
CONCLUSIONS: Small cell undifferentiated histology may have an unfavorable effect on outcome in patients with completely resected hepatoblastoma. The focal distribution of small cell histology in the majority of these tumors suggests that treating hepatoblastoma based on limited preexcision biopsies may deprive some patients of appropriate therapy. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11753992     DOI: 10.1002/1097-0142(20011215)92:12<3130::aid-cncr10115>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.

Authors:  Goutam Bera; Ram Narayan Das; Paromita Roy; Ranajoy Ghosh; Nelofar Islam; Prafulla Kumar Mishra; Uttara Chatterjee
Journal:  Pediatr Surg Int       Date:  2017-06-19       Impact factor: 1.827

2.  The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.

Authors:  Laura L Stafman; Mary G Waldrop; Adele P Williams; Jamie M Aye; Jerry E Stewart; Elizabeth Mroczek-Musulman; Karina J Yoon; Kimberly Whelan; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2019-02-28       Impact factor: 2.545

3.  Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

Authors:  Howard M Katzenstein; Wayne L Furman; Marcio H Malogolowkin; Mark D Krailo; M Beth McCarville; Alexander J Towbin; Greg M Tiao; Milton J Finegold; Sarangarajan Ranganathan; Stephen P Dunn; Max R Langham; Eugene D McGahren; Carlos Rodriguez-Galindo; Rebecka L Meyers
Journal:  Cancer       Date:  2017-02-17       Impact factor: 6.860

4.  Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee.

Authors:  Christopher B Weldon; Arin L Madenci; Gregory M Tiao; Stephen P Dunn; Max R Langham; Eugene D McGahren; Sarangarajan Ranganathan; Dolores H López-Terrada; Milton J Finegold; Marcio H Malogolowkin; Jin Piao; Li Huang; Mark D Krailo; Rebecka L Meyers; Howard M Katzenstein
Journal:  J Pediatr Surg       Date:  2019-05-11       Impact factor: 2.545

5.  Hepatoblastomas in Oman: Unveiling success.

Authors:  Fatma Rabah; Nagwa El-Banna; Dipali Bhuyan; Ibrahim Al-Ghaithi; Mohamed Al-Hinai; Amal Al-Sabahi; Nawal Al-Mashaikhi; Ismail Beshlawi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

6.  Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Authors:  Marcio H Malogolowkin; Howard M Katzenstein; Rebecka L Meyers; Mark D Krailo; Jon M Rowland; Joel Haas; Milton J Finegold
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

7.  SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?

Authors:  Pierre Russo; Jaclyn A Biegel
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

8.  Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.

Authors:  Angela D Trobaugh-Lotrario; Gail E Tomlinson; Milton J Finegold; Lia Gore; James H Feusner
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

9.  Genome-wide analysis of DNA methylation in hepatoblastoma tissues.

Authors:  Ximao Cui; Baihui Liu; Shan Zheng; Kuiran Dong; Rui Dong
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

10.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.